Finance News – Zebound
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Shares
Tariffs
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Bse
Xrp
Etf
Stablecoin
Investment
Blockchain
Ipo
Eth
Index
Solana
Sec
Trade
Inflation
Earnings
Interest Rates
Revenue
Sensex
Token
Coinbase
Wall Street
Treasury
Nasdaq
Nse
Federal Reserve
China
Traders
Bse Sensex
Nifty
Gold
Sp 500
Investor
Tesla
Profit
Economy
Company
Supermarkets
Hbar
Harbour Energy
Tournament
Kucoin Pay
Conservatives
Bitcoin Treasury Firms
5g Services
Wires And Cables Sector
Just Price
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 16, 2025
Healthy Returns: Chinese obesity drug emerges as a potential rival to Eli Lilly’s Zepbound
The success of a new obesity medication in China could challenge existing market leaders, potentially shifting investment dynamics within the pharmaceutical sector and impacting fu...
Read Full Article →